Publications
Vet Comp Oncol, Oncotarget, Veterinary Sciences, Mol. Cancer, J. Am. Chem. Soc., Mol Clin Oncol, JAMA Dermatol, Mol. Cancer Res., Am. J. Pathol., Bioconjug. Chem., Ecancermedicalscience, Res. Vet. Sci., Exp. Cell Res., Nanomedicine, Gynecol. Oncol., Vasc Cell, Oncoscience, BMC Cancer, Mol Carcinog., PLoS ONE, Lab. Invest., Transl Oncol, Vet Comp Oncol., Cancer Lett., Biomed J, Taiwan J Obstet Gynecol, Neoplasia, Int. J. Cancer, Inflamm Res.,
- Duckett MM, Phung SK, Nguyen L, Khammanivong A, Dickerson EB, Dusenbery K, Lawrence J. The adrenergic receptor antagonists propranolol and carvedilol decrease bone sarcoma cell viability and sustained carvedilol reduces clonogenic survival and increases radiosensitivity in canine osteosarcoma cells Vet Comp Oncol 2019;
PMID: 31778284
- Borgatti A, Dickerson EB, Lawrence J. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional Vet Comp Oncol 2019;
PMID: 31749286
- Khammanivong A, Saha J, Spartz AK, Sorenson BS, Bush AG, Korpela DM, Gopalakrishnan R, Jonnalagadda S, Mereddy VR, O'Brien TD, Drewes LR, Dickerson EB.. A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma Vet Comp Oncol 2019;
PMID: 31661586
- Montoya A, Varela-Ramirez A, Dickerson E, Pasquier E, Torabi A, Aguilera R, Nahleh Z, Bryan B. The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer Biomed J 2019; 42(3):155-165
PMID: 31466709
- Ballou Y, Rivas A, Belmont A, Patel L, Amaya CN, Lipson S, Khayou T, Dickerson EB, Nahleh Z, Bryan BA. 5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability Mol Clin Oncol 2018; 9(3):243-254
PMID: 30155245
- Pantziarka P, Bryan BA, Crispino S, Dickerson EB. Propranolol and breast cancer-a work in progress Ecancermedicalscience 2018;
PMID: 30034523
- Amaya CN, Perkins M, Belmont A, Herrera C, Nasrazadani A, Vargas A, Khayou T, Montoya A, Ballou Y, Galvan D, Rivas A, Rains S, Patel L, Ortega V, Lopez C, Chow W, Dickerson EB, Bryan BA. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma Oncoscience 2018; 5(3-4):124-134
DOI: 10.18632/oncoscience.413
- Kim J-H, Frantz AM, Sarver AL, Gorden Klukas BH, Lewellen M, O'Brien TD, Dickerson EB, Modiano JF. Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers Vet Comp Oncol 2018; 16(1):E176-E184
PMID: 29152836
- Walz JZ, Saha J, Arora A, Khammanivong A, O'Sullivan MG, Dickerson EB. Fatty acid synthase as a potential therapeutic target in feline oral squamous cell carcinoma Vet Comp Oncol 2018; 16(1):E99-E108
PMID: 28871635
- Montoya A, Amaya CN, Belmont A, Diab N, Trevino R, Villanueva G, Rains S, Sanchez LA, Badri N, Otoukesh S, Khammanivong A, Liss D, Baca ST, Aguilera RJ, Dickerson EB, Torabi A, Dwivedi AK, Abbas A, Chambers K, Bryan BA, Nahleh Z. Use of non-selective β-blockers is associated with decreased tumor proliferative indices in early stage breast cancer Oncotarget 2017; 8(4):6446-6460
PMID: 28031536
- Khammanivong A*, Gorden BH*, Frantz A, Graef AJ, Dickerson EB. Identification of drug resistant subpopulations in canine hemangiosarcoma. Vet Comp Oncol. 2016; 14(3):e113-25
PMID: 25112808
- Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MC. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Oncotarget 2016; 7(12):14029-47
PMID: 26883112
- Khammanivong A, Anandharaj A, Qian X, Song JM, Upadhyaya P, Balbo S, Bandyopadhyay D, Dickerson EB, Hecht SS, Kassie F. Transcriptome profiling in oral cavity and esophagus tissues from (S)-N'-nitrosonornicotine-treated rats reveals candidate genes involved in human oral cavity and esophageal carcinogenesis. Mol Carcinog. 2016; 55(12):2168-2182
PMID: 26785143
- Kim J-H, Graef AJ, Dickerson EB, Modiano JF. Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives progression and potential for targeted intervention. Veterinary Sciences 2015; 2:388-405
DOI: 10.3390/vetsci2040388
- Chow W, Amaya CN, Rains S, Chow M, Dickerson EB, Bryan BA. Growth attenuation of cutaneous angiosarcoma with propranolol-mediated β-blockade. JAMA Dermatol 2015; 151(11):1226-9
PMID: 26375166
- Dickerson EB and Bryan BA. Beta Adrenergic Signaling: A targetable regulator of angiosarcoma and hemangiosarcoma. Veterinary Sciences 2015; 2:270-292
DOI: 10.3390/vetsci2030270
- Qian X, Khammanivong A, Song JM, Teferi F, Upadhyaya P, Dickerson E, Kassie F. RNA-sequencing studies identify genes differentially regulated during inflammation-driven lung tumorigenesis and targeted by chemopreventive agents. Inflamm Res. 2015; 64(5):343-361
PMID: 25795230
- Wu GJ, Dickerson EB. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma. Taiwan J Obstet Gynecol 2014; 53(4):509-17
PMID: 25510693
- Khammanivong A, Gopalakrishnan R, Dickerson EB. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma. Mol. Cancer 2014; 13:260
PMID: 25471937
- Gorden BH, Saha J, Khammanivong A, Schwartz GK, Dickerson EB. Lysosomal drug sequestration as a mechanism of drug resistance in vascular sarcoma cells marked by high CSF-1R expression. Vasc Cell 2014; 6:20
PMID: 25295160
- Kim JH, Frantz AM, Anderson KL, Graef AJ, Scott MC, Robinson S, Sharkey LC, O'Brien TD, Dickerson EB, Modiano JF. Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment. Exp. Cell Res. 2014; 323(1):155-64
PMID: 24582862
- Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O'Brien TD, Sharkey LC, Modiano JF, Dickerson EB. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am. J. Pathol. 2014; 184(4):985-95
PMID: 24525151
- Schappa JT, Frantz AM, Gorden BH, Dickerson EB, Vallera DA, Modiano JF. Hemangiosarcoma and its cancer stem cell subpopulation are effectively killed by a toxin targeted through epidermal growth factor and urokinase receptors. Int. J. Cancer 2013; 133(8):1936-44
PMID: 23553371
- Dickerson EB, Marley K, Edris W, Tyner JW, Schalk V, Macdonald V, Loriaux M, Druker BJ, Helfand SC. Imatinib and Dasatinib Inhibit Hemangiosarcoma and Implicate PDGFR-β and Src in Tumor Growth. Transl Oncol 2013; 6(2):158-68
PMID: 23544168
- Dickerson EB, Dreaden EC, Huang X, El-Sayed IH, Chu H, Pushpanketh S, McDonald JF, El-Sayed MA. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 2008; 269(1):57-66
PMID: 18541363
- Scarberry KE, Dickerson EB, McDonald JF, Zhang ZJ. Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells. J. Am. Chem. Soc. 2008; 130(31):10258-62
PMID: 18611005
- Moreno CS, Matyunina L, Dickerson EB, Schubert N, Bowen NJ, Logani S, Benigno BB, McDonald JF. Evidence that p53-mediated cell-cycle-arrest inhibits chemotherapeutic treatment of ovarian carcinomas. PLoS ONE 2007; 2(5):e441
PMID: 17505532
- Menendez L, Walker D, Matyunina LV, Dickerson EB, Bowen NJ, Polavarapu N, Benigno BB, McDonald JF. Identification of candidate methylation-responsive genes in ovarian cancer. Mol. Cancer 2007; 6:10
PMID: 17254359
- Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol. Oncol. 2007; 104(2):331-7
PMID: 17064757
- Dickerson EB, Akhtar N, Steinberg H, Wang ZY, Lindstrom MJ, Padilla ML, Auerbach R, Helfand SC. Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to alphavbeta3 integrin. Mol. Cancer Res. 2004; 2(12):663-73
PMID: 15634755
- Akhtar N, Padilla ML, Dickerson EB, Steinberg H, Breen M, Auerbach R, Helfand SC. Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model. Neoplasia 2004; 6(2):106-16
PMID: 15140399
- Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J, Breen M, Helfa. Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab. Invest. 2004; 84(5):562-72
PMID: 15064773